No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
VERV240816C12500
- 0.09
- +0.02+28.57%
15min DelayClose Jul 22 16:00 ET
0.09High0.05Low
0.05Open0.07Pre Close51 Volume138 Open Interest12.50Strike Price259.00Turnover176.65%IV75.35%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type0.1705Delta0.0759Gamma28.72Leverage Ratio-0.0168Theta0.0007Rho4.90Eff Leverage0.0048Vega
Intraday
- 5D
- Daily
News
Companies Like Verve Therapeutics (NASDAQ:VERV) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring
RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk
Verve Therapeutics (VERV) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $15 to $40.
Express News | Verve Therapeutics Inc : RBC Cuts Target Price to $25 From $35
Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now?
Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally
On Wednesday, Cathie Wood-led Ark Invest made a notable move by offloading a significant number of shares in Tesla Inc (NASDAQ:TSLA), despite the recent rally driven by the company's impressive second
Express News | Verve Therapeutics Inc - Increased Size of Board to Nine Members
Comments
How does the biotech ecosystem support advancements in personalized medicine & genomics? ![]()
• Editing Genes | $CRISPR Therapeutics(CRSP.US$ , $Intellia Therapeutics(NTLA.US$ , $Beam Therapeutics(BEAM.US$ , $Verve Therapeutics(VERV.US$ , $Editas Medicine(EDIT.US$
• Creating Therapies | $Prime Medicine(PRME.US$ , $Sana Biotechnology(SANA.US$
• Building DNA | $Twist Bioscience(TWST.US$ , $Ginkgo Bioworks(DNA.US$ , $Pacific Biosciences of California(PACB.US$ , $Illumina(ILMN.US$
• Dis...
• Editing Genes | $CRISPR Therapeutics(CRSP.US$ , $Intellia Therapeutics(NTLA.US$ , $Beam Therapeutics(BEAM.US$ , $Verve Therapeutics(VERV.US$ , $Editas Medicine(EDIT.US$
• Creating Therapies | $Prime Medicine(PRME.US$ , $Sana Biotechnology(SANA.US$
• Building DNA | $Twist Bioscience(TWST.US$ , $Ginkgo Bioworks(DNA.US$ , $Pacific Biosciences of California(PACB.US$ , $Illumina(ILMN.US$
• Dis...
7
On Monday, Cathie Wood’ s Ark Invest made some significant trades, the most notable being the purchase of $Shopify(SHOP.US$ and the sale od $Block(SQ.US$
The Shopify Trade
$ARK Fintech Innovation ETF(ARKF.US$ $ARK Innovation ETF(ARKK.US$ and $ARK Next Generation Internet ETF(ARKW.US$ Purchased a total of 313,¢3 shares of Shopify on Monday. This move came after the company ...
The Shopify Trade
$ARK Fintech Innovation ETF(ARKF.US$ $ARK Innovation ETF(ARKK.US$ and $ARK Next Generation Internet ETF(ARKW.US$ Purchased a total of 313,¢3 shares of Shopify on Monday. This move came after the company ...
4
4
$Verve Therapeutics(VERV.US$ Verve Therapeutics Announces Dosing Of First Patient In Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
Read more